Einde inhoudsopgave
Remedies for infringements of EU law in legal relationships between private parties (LBF vol. 18) 2019/5.2.2.2
5.2.2.2 The ruling of the Court of Justice in a nutshell
mr. I.V. Aronstein, datum 01-09-2019
- Datum
01-09-2019
- Auteur
mr. I.V. Aronstein
- JCDI
JCDI:ADS141365:1
- Vakgebied(en)
EU-recht / Algemeen
Burgerlijk procesrecht / Algemeen
Voetnoten
Voetnoten
Ibid., para. 17. CJ 9 November 2010, Joined Cases C-92/09 and C-93/09 (Volker), para. 46.
CJ 1 March 2011, Case C-236/09 (Test-Achats), para. 26.
Ibid., paras. 21 and 28-32. Cf. Murphy 2011, p. 289. Armbrüster 2011, under (2) Rechtliche Wertung. Effer-Uhe 2011, pp. 110-111. K. Lenaerts 2013, pp. 1313-1316.
CJ 1 March 2011, Case C-236/09 (Test-Achats), paras. 21 and 28-32. In its judgment the Court of Justice did not carry out a substantive compatibility review of Article 5(2) Directive against Articles 21 and 23 Charter or against the principle of equal treatment. Therefore, the exact role of the relevant Charter provisions remains up in the air. Cf. K. Lenaerts 2013, pp. 1322-1323. Watson 2011, p. 900. Armbrüster2011. Thiery 2011a, paras. 7-8. Tobler 2011, pp. 2053-2054. Lüttringhaus 2011, pp. 297-298. Borgesius2012, p. 104. Effer-Uhe 2011. Schwintowski & Enke 2011.
See for instance CJ 8 April 1976, Case 43/75 (Defrenne II), paras. 74 and 75. CJ 27 March 1980, Case 61/79 (Denkavit Italiana), paras. 16-18. CJ 3 October 2002, Case C-347/00 (Barreira Pérez), paras. 44-45.
CJ 1 March 2011, Case C-236/09 (Test-Achats), paras. 33-34. The date was not randomly chosen: it coincides with the date upon which the Member States that made use of the option under Article 5(2) Directive to derogate should have reviewed their decision. Besides Test-Achats, thus far, there have not been other cases in which the European Court saw reason to restrict the effect of invalidity by adopting a transitional period. Usually, the CJ is of the opinion that overriding conditions of legal certainty lack. See for instance CJ 28 January 1998, Case C-315/96 (Lopex). Cf. Tobler 2011, p. 2058.
See for example the reaction of the European Association of Insurers and Re-insurers: “CEA regrets ECJ judgement on use of gender in insurance pricing”, 1 March 2011, available on < http://www.eubusiness.com/Members/CEA/insurance-11/ > [Lastly consulted on 21 August 2019]. “Discrimination in the market place”, Financial Times, 1 March 2011. “European Court bans gender as factor in insurance”, The New York Times, 1 March 2011. E.g. Pfeiffer2011. More (mostly German) literature is discussed below.
Cf. Armbrüster2011, (2) Rechtliche Wertung. Lüttringhaus 2011, p. 298. Kalkman 2011. Borgesius2012, pp. 104-105. Effer-Uhe 2011, pp. 111-113. Schanze 2013, p. 424. Temming 2012, especially at pp. 111-119.
Opinion Kokott 30 September 2010, Case C-236/09 (Test-Achats), especially paras. 59-71. Thiery 2011c.
Cf. Lüttringhaus 2011, p. 298. Karpenstein 2010, pp. 885-886. Armbrüster 2010, pp. 1578-1583. Armbrüster2011, paras. 2 and 3. Schwintowski 2011. Sagmeister 2011, p. 187. Hoffmann 2011, pp. 1445-1446. Effer-Uhe 2011, pp. 114-128. Schwintowski & Enke 2011.
231. Although the applicants based their complaint upon Article 6(2) TEU, the Court of Justice argues that the validity of the Directive is to be assessed in light of Articles 21 and 23 Charter.1 Under Article 5(2) Directive, any decision to make use of the option to derogate is to be reviewed five years after 21 December 2007, account being taken of a Commission report. However, the Directive does not make the permissibility of insurers to apply unequal treatment of men and women subject to any temporal limitation.2 Due to this unlimited option of derogating from the unisex rule provided for in Article 5(2) Directive, there is a risk that Union law may indefinitely permit the derogation from equal treatment. The option to derogate from the unisex rule without any temporal limitation, sabotages the purpose of the Directive and is on that account incompatible with Articles 21 and 23 Charter.3 Consequently, the Court holds that Article 5(2) is incoherent with the Directive’s objectives and is, as a result of this incoherency, invalid.4
232. Only by way of exception does the Court of Justice limit or suspend the effect of an interpretation or a declaration of invalidity of a Union measure, that is, only in the event that the Court finds overriding considerations of legal certainty that justify such a limitation.5 Without giving insight into its reasoning, the Court concludes that “Article 5(2) of Directive 2004/113 is invalid with effect from 21 December 2012”, which according to the Court is “an appropriate transitional period”.6 In consequence, until this date the provision is valid, despite the fact that its application – conceivably – results in gender discrimination.
233. The Court’s judgment caused turmoil not only in the insurance sector, but also the press and literature – especially German literature – are scornful.7 By focussing on the coherency issues the Court de facto bypassed the substantive compatibility review of the gender discrimination allowed by Article 5(2) Directive against the general principle of equal treatment between men and women.8 Advocate General Kokott argues9 that the use of gender as a substitute criterion for other distinguishing factors in the assessment of insurance risks is of itselfin conflict with Articles 21 and 23 Charter.10 However, it cannot be derived from the judgment in Test-Achats that the Court of Justice requires unisex tariffs.